Profile | GDS4284 / 219209_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 4295.86 | 92 |
GSM687648 | Patient 402 control | 3099.09 | 89 |
GSM687653 | Patient 403 control | 2543.76 | 87 |
GSM687658 | Patient 404 control | 3449.82 | 90 |
GSM687663 | Patient 411 control | 1926.54 | 83 |
GSM687668 | Patient 422 control | 2022.92 | 84 |
GSM687673 | Patient 424 control | 2972.31 | 89 |
GSM687678 | Patient 425 control | 4640.69 | 93 |
GSM687683 | Patient 427 control | 2534.36 | 87 |
GSM687688 | Patient 428 control | 2357.11 | 86 |
GSM687695 | Patient 441 control | 3215.07 | 90 |
GSM687699 | Patient 443 control | 2095.3 | 85 |
GSM687704 | Patient 444 control | 2266.71 | 85 |
GSM687707 | Patient 448 control | 2747.01 | 88 |
GSM687712 | Patient 449 control | 3139.82 | 89 |
GSM687719 | Patient 450 control | 2941.23 | 89 |
GSM687724 | Patient 451 control | 3150.99 | 89 |
GSM687728 | Patient 452 control | 2163.52 | 85 |
GSM687646 | Patient 401 treated 24h | 3018.42 | 89 |
GSM687649 | Patient 402 treated 24h | 2529.5 | 86 |
GSM687665 | Patient 411 treated 24h | 2587.39 | 87 |
GSM687651 | Patient 402 treated 4 weeks | 2680 | 88 |
GSM687667 | Patient 411 treated 4 weeks | 2676.18 | 87 |
GSM687670 | Patient 422 treated 24h | 2091.08 | 84 |
GSM687671 | Patient 422 treated 4 weeks | 1878.14 | 83 |
GSM687654 | Patient 403 treated 24h | 2794.15 | 88 |
GSM687675 | Patient 424 treated 24h | 3314.47 | 90 |
GSM687685 | Patient 427 treated 24h | 2278.12 | 86 |
GSM687656 | Patient 403 treated 4 weeks | 2513.88 | 87 |
GSM687677 | Patient 424 treated 4 weeks | 2871 | 88 |
GSM687687 | Patient 427 treated 4 weeks | 2340.36 | 86 |
GSM687692 | Patient 428 treated 4h | 2384.36 | 86 |
GSM687716 | Patient 449 treated 4h | 2998.27 | 89 |
GSM687722 | Patient 450 treated 4h | 4192.37 | 92 |
GSM687680 | Patient 425 treated 24h | 5360.98 | 94 |
GSM687690 | Patient 428 treated 24h | 3150.63 | 89 |
GSM687700 | Patient 443 treated 24h | 3649.39 | 91 |
GSM687705 | Patient 444 treated 24h | 4131.37 | 92 |
GSM687714 | Patient 449 treated 24h | 3427.68 | 90 |
GSM687721 | Patient 450 treated 24h | 3200.86 | 90 |
GSM687682 | Patient 425 treated 4 weeks | 4679.67 | 93 |
GSM687694 | Patient 428 treated 4 weeks | 2636.24 | 87 |
GSM687702 | Patient 443 treated 4 weeks | 2213.93 | 85 |
GSM687718 | Patient 449 treated 4 weeks | 3230.54 | 90 |
GSM687723 | Patient 450 treated 4 weeks | 2494 | 87 |
GSM687661 | Patient 404 treated 4h | 4453.54 | 92 |
GSM687710 | Patient 448 treated 4h | 2993.51 | 89 |
GSM687726 | Patient 451 treated 4h | 3192.66 | 89 |
GSM687730 | Patient 452 treated 4h | 2001.74 | 85 |
GSM687660 | Patient 404 treated 24h | 8814.7 | 96 |
GSM687697 | Patient 441 treated 24h | 2542.57 | 87 |
GSM687709 | Patient 448 treated 24h | 3315.96 | 90 |
GSM687725 | Patient 451 treated 24h | 3711.21 | 91 |
GSM687729 | Patient 452 treated 24h | 2383.61 | 87 |
GSM687727 | Patient 451 treated 4 weeks | 2325.56 | 86 |
GSM687731 | Patient 452 treated 4 weeks | 3591.44 | 91 |